BreadcrumbHome / Investors / Events and Presentations / Event Details Event Details Jump Links - All Pages OverviewPress ReleasesEvents and PresentationsSEC FilingsCorporate GovernanceStock Information Ocular Therapeutix™ Announces FDA Approval of DEXTENZA® for the Treatment of Post-Operative Pain Following Ocular Surgery December 3, 2018 at 8:30 AM EST Click here for webcast Additional Resources Investor FAQsInformation Request
Ocular Therapeutix™ Announces FDA Approval of DEXTENZA® for the Treatment of Post-Operative Pain Following Ocular Surgery December 3, 2018 at 8:30 AM EST Click here for webcast